相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression
Richard E. Clark et al.
BLOOD ADVANCES (2021)
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
Yotaro Ochi et al.
NATURE COMMUNICATIONS (2021)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Ruediger Hehlmann et al.
LEUKEMIA (2020)
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Susan Branford et al.
BLOOD (2018)
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R. Hehlmann et al.
LEUKEMIA (2017)
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
Zimu Gong et al.
BLOOD ADVANCES (2017)
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Wei Wang et al.
BLOOD (2016)
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Alice Fabarius et al.
BLOOD (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
B Johansson et al.
ACTA HAEMATOLOGICA (2002)
分享论文
